Shanghai Yuyao Biotech Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Shanghai Yuyao Biotech Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies (NCT06225856) | Shanghai Yuyao Biotech Co., Ltd. | 2023-10-26 |
| An Phase I Study of YY001 in Patients with Advanced Solid Tumors (NCT06228846) | Shanghai Yuyao Biotech Co., Ltd. | 2022-07-14 |
Track Shanghai Yuyao Biotech Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.